Needham analyst Vikram Bagri upgrades Tesla (NASDAQ:TSLA) from Underperform to Hold.
Flexing On Muscular Dystrophy, Analyst Expects Almost 200% Upside For Edgewise Therapeutics
Truist initiated coverage on Edgewise Therapeutics Inc (NASDAQ: EWTX) with a Buy rating and a